S. Muoio & Co. LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
S. Muoio & Co. LLC
- $75.7 Million
- Q3 2022
A detailed history of S. Muoio & Co. LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, S. Muoio & Co. LLC holds 18,980 shares of BHVN stock, worth $695,806. This represents 3.79% of its overall portfolio holdings.
Number of Shares
18,980
Previous 13,500
40.59%
Holding current value
$695,806
Previous $1.97 Million
45.86%
% of portfolio
3.79%
Previous 2.8%
Shares
2 transactions
Others Institutions Holding BHVN
# of Institutions
11Shares Held
792KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL710KShares$26 Million17.51% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$1.32 Million0.01% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$423,7890.16% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$270,0000.34% of portfolio
-
Brevan Howard Capital Management LP St. Helier, Y96.52KShares$239,1330.0% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $2.63B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...